Embecta Corp. (EMBC)
USD 12.27
(2.12%)
USD 12.27
(2.12%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.31 Billion USD | -0.07% |
| 2022 | 1.31 Billion USD | 32722.5% |
| 2021 | 4 Million USD | -20.0% |
| 2020 | 5 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.34 Billion USD | 0.8% |
| 2024 Q1 | 1.33 Billion USD | 2.02% |
| 2024 Q3 | 1.37 Billion USD | 0.73% |
| 2023 Q1 | 1.25 Billion USD | -4.23% |
| 2023 FY | 1.31 Billion USD | -0.07% |
| 2023 Q4 | 1.31 Billion USD | -0.79% |
| 2023 Q3 | 1.32 Billion USD | 2.15% |
| 2023 Q2 | 1.29 Billion USD | 2.97% |
| 2022 Q4 | 1.31 Billion USD | -2.96% |
| 2022 Q2 | 1.34 Billion USD | 0.0% |
| 2022 FY | 1.31 Billion USD | 32722.5% |
| 2022 Q3 | 1.35 Billion USD | 0.52% |
| 2022 Q1 | - USD | -100.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | 4 Million USD | -20.0% |
| 2021 Q4 | 3 Million USD | 0.0% |
| 2020 FY | 5 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -71137.601% |
| Alpha Teknova, Inc. | 1.97 Million USD | -66364.032% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | -1292.678% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | -1650.5% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | -201.376% |
| Cosmos Health Inc. | 8.59 Million USD | -15172.228% |
| Journey Medical Corporation | -9.7 Million USD | 13613.235% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | -186.026% |
| Dynavax Technologies Corporation | 106.63 Million USD | -1130.365% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 1102.836% |
| Pacira BioSciences, Inc. | 432.74 Million USD | -203.18% |
| PainReform Ltd. | -7.95 Million USD | 16603.145% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 8491.622% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 8491.622% |
| SCYNEXIS, Inc. | -19.35 Million USD | 6880.362% |
| Safety Shot Inc | -2.28 Million USD | 57533.653% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 14013.439% |
| Procaps Group, S.A. | 242.93 Million USD | -440.069% |
| Theratechnologies Inc. | 24.87 Million USD | -5175.22% |
| Harrow Health, Inc. | 116.41 Million USD | -1026.983% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 52163.492% |
| Biofrontera Inc. | 4.05 Million USD | -32247.14% |
| DURECT Corporation | -7.65 Million USD | 17241.364% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 4013.264% |
| Cronos Group Inc. | -663.32 Million USD | 297.791% |
| OptiNose, Inc. | 58.06 Million USD | -2159.537% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | -110.464% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 9103.568% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 25398.73% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -8639.093% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 20730.079% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -1227686.148% |
| Radius Health, Inc. | 359.28 Million USD | -265.174% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -665184.039% |
| ProPhase Labs, Inc. | 19.23 Million USD | -6722.318% |
| Phibro Animal Health Corporation | 454.84 Million USD | -188.449% |
| Procaps Group S.A. | 242.93 Million USD | -440.069% |
| Alvotech | 1.06 Billion USD | -23.272% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -35571.561% |
| Viatris Inc. | 17.13 Billion USD | 92.341% |
| Rockwell Medical, Inc. | 4.45 Million USD | -29343.447% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 27001.784% |
| SIGA Technologies, Inc. | -148.68 Million USD | 982.421% |
| Tilray Brands, Inc. | 158.97 Million USD | -725.277% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | -976.31% |
| Shineco, Inc. | 29.29 Million USD | -4379.298% |
| PetIQ, Inc. | 351.93 Million USD | -272.798% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 45319.113% |
| Incannex Healthcare Limited | -5.48 Million USD | 24019.781% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | -639.989% |
| Alimera Sciences, Inc. | 55.3 Million USD | -2272.128% |
| Silver Spike Investment Corp. | -32.61 Million USD | 4123.104% |
| Assertio Holdings, Inc. | -32.52 Million USD | 4133.324% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 88229.281% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 26026.886% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 27353.843% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 16073.747% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -31012.165% |
| Hempacco Co., Inc. | 13.61 Million USD | -9536.657% |
| Talphera, Inc. | -5.72 Million USD | 23033.054% |
| Alvotech | 1.06 Billion USD | -23.272% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -18262.491% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 1456.633% |
| Currenc Group, Inc. | -16.57 Million USD | 8016.431% |
| Kamada Ltd. | -46.43 Million USD | 2925.667% |
| Indivior PLC | -33.95 Million USD | 3964.28% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -503403.803% |
| Flora Growth Corp. | -713 Thousand USD | 184111.22% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 16073.747% |
| Evolus, Inc. | 63.7 Million USD | -1959.396% |
| HUTCHMED (China) Limited | -197.45 Million USD | 764.445% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | -173.841% |
| Akanda Corp. | 3.9 Million USD | -33498.674% |